Early Thoracic Duct Ligation for Post-esophagectomy Chyle Leak: A 10-Year Institutional Experience With Early Operative Intervention
Parvinder Singh, Gurmeet Singh, Gurlal Singh, Pawan Kumar, Gaurav Goel

TL;DR
This study shows that early surgery to treat chyle leaks after esophagectomy is safer and more effective than conservative treatment.
Contribution
The study provides evidence supporting early thoracic duct ligation as a novel treatment strategy for high-output chyle leaks.
Findings
Early surgical ligation resolved all cases with no mortality, compared to 100% mortality with conservative therapy.
Patients treated surgically had shorter hospital stays than those receiving conservative treatment.
Chyle leak patients were significantly younger than those without leaks.
Abstract
Background and aim Chyle leak is a rare but potentially lethal complication following esophagectomy. Optimal timing for thoracic duct ligation remains unclear, particularly for high-output leaks. This study aimed to evaluate outcomes of early thoracic duct ligation compared with conservative therapy in post-esophagectomy chyle leak. Methods This is a retrospective study of 500 patients undergoing esophagectomy from 2016 to 2025 at a tertiary cancer center. Six patients (1.2%) developed chyle leak. Diagnosis was based on high-volume drainage, milky effluent after feeding, and biochemical confirmation. Conservative treatment included drainage, nil per oral, and total parenteral nutrition. Early thoracic duct ligation was performed via a transthoracic or transabdominal approach. Statistical tests included the t-test and Fisher’s exact test. Results Patients with chyle leak were…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Parameters | Values | |
| Age, years (mean±SD) | 53.2±13.4 | |
| Sex, n (%) | Male | 230 (46) |
| Female | 270 (54) | |
| Histopathology, n (%) | Squamous cell carcinoma | 325 (65) |
| Adenocarcinoma | 175 (35) | |
| Tumor location, n (%) | Upper third | 90 (18) |
| Middle third | 235 (47) | |
| Lower third/GE junction | 175 (35) | |
| Surgical approach, n (%) | Transthoracic | 350 (70) |
| Transhiatal | 150 (30) | |
| Duration of surgery, hours (mean±SD) | 5.6±1.1 | |
| Blood loss, mL (mean±SD) | 1020±380 | |
| Mean hospital stay, days (mean±SD) | 14.3±4.9 | |
| ICU stay, days (mean±SD) | 3.2±1.4 | |
| Parameters | Chyle leak (n=6) | No chyle leak (n=494) | Test statistic* | p-Value |
| Mean age, years (mean±SD) | 44.0±5.7 | 53.2±13.4 | t=2.63 | 0.009** |
| Male sex, n (%) | 5 (83) | 225 (46) | χ²=1.78 | 0.18 |
| Duration of surgery (h) | 5.8±0.9 | 5.6±1.1 | t=0.47 | 0.64 |
| Blood loss (mL) | 1100±450 | 1020±380 | t=0.60 | 0.55 |
| ICU stay (days) | 3.8±1.3 | 3.2±1.4 | t=0.85 | 0.40 |
| Mortality, n (%) | 1 (16.7) | 24 (4.8) | Fisher’s exact | 0.28 |
| Case number | Age (years) | Sex | Output (mL/day) | Management | Surgical approach | POD of surgery | Outcome |
| 1 | 42 | Male | 1200 | Surgical ligation | Right thoracotomy | POD 3 | Recovered |
| 2 | 46 | Male | 1500 | Surgical ligation | Right thoracotomy | POD 2 | Recovered |
| 3 | 39 | Male | 1000 | Surgical ligation | Transabdominal suprahiatal | POD 3 | Recovered |
| 4 | 45 | Female | 900 | Surgical ligation | Transabdominal suprahiatal | POD 2 | Recovered |
| 5 | 48 | Male | 1100 | Surgical ligation | Right thoracotomy | POD 2 | Recovered |
| 6 | 44 | Male | 1300 | Conservative (failed) | - | - | Death (POD 18) |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLymphatic Disorders and Treatments · Pleural and Pulmonary Diseases · Lymphatic System and Diseases
Introduction
Chyle leak following esophagectomy, although uncommon, is associated with significant morbidity. Reported incidence ranges from 1% to 4% in major surgical series [1-3]. Loss of lymphatic fluid leads to progressive depletion of proteins, fats, electrolytes, and lymphocytes, resulting in immunosuppression, malnutrition, respiratory compromise, and increased susceptibility to infection [4-6]. Historically, mortality from untreated or delayed chyle leak was substantial [5,6].
Mechanisms contributing to thoracic duct injury include extensive mediastinal lymphadenectomy, difficult dissection in the middle third of the esophagus, and unrecognized variations in thoracic duct anatomy [7,8]. Such anomalies complicate intraoperative identification. Early diagnosis is crucial but often delayed due to non-specific post-operative symptoms such as dyspnea or increased drain output.
Conservative management, nil per oral, total parenteral nutrition, and continued drainage are generally recommended for low-output leaks. However, high-output leaks seldom resolve without surgery and are associated with metabolic deterioration and increased mortality [3,9]. Surgical interventions described in literature range from thoracotomy to minimally invasive thoracic duct ligation, with excellent outcomes when performed early [7,10,11].
Additional diagnostic and therapeutic adjuncts, such as lymphangiography and thoracic duct embolization, have gained attention in recent years, though accessibility varies significantly across institutions [12-15]. Prophylactic thoracic duct ligation remains controversial, with mixed outcomes reported [16]. Given these uncertainties, institutional experiences contribute valuable insight. This study analyzes a decade of post-operative outcomes at a tertiary cancer center, focusing on the role of early surgical ligation compared with conservative management.
Materials and methods
This retrospective, descriptive, observational study was conducted at the Advanced Cancer Institute, Bathinda, and included all patients who underwent esophagectomy between January 2016 and October 2025. Both transthoracic (Ivor Lewis) and transhiatal esophagectomies were included. Patient demographics, operative variables, post-operative course, and outcomes were collected from institutional records.
For the purpose of this study, high-output chyle leak was defined as drainage ≥800 mL/day persisting for more than 48 h; milky drainage following the initiation of enteral feeding; or biochemical confirmation with pleural fluid triglyceride level exceeding 110 mg/dL or detection of chylomicrons. Once diagnosed, all patients were placed on a standardized management pathway.
Following confirmation of post-operative chyle leak, all patients were evaluated for daily drain output, clinical stability, and biochemical parameters. Patients and their attendants were formally counselled regarding the available treatment options, including conservative management and early thoracic duct ligation. The potential benefits, risks, likelihood of success, and possible complications of each approach were explained in detail.
While objective clinical criteria, such as drainage volume, persistence of leak, and physiological deterioration, guided the treating team’s recommendation, the final management decision was made through a shared decision-making process after obtaining informed consent from the patient or attendant. Conservative management was considered for low-output leaks. Early thoracic duct ligation was advised for high-output leaks (≥800 mL/day) based on institutional practice favoring definitive control. Final treatment decisions were individualized after shared clinical counseling.
Conservative therapy consisted of continued drainage, nil per oral status, total parenteral nutrition, intravenous fluids, and electrolyte correction. Octreotide was used selectively based on clinical judgment and drainage pattern. Early thoracic duct ligation was defined as operative intervention within 48-72 h of confirmed diagnosis. All surgeries were performed by experienced thoracic and gastrointestinal oncology surgeons via either a right thoracotomy or a transabdominal suprahiatal approach. Fatty cream (100-200 mL) was administered via jejunostomy 2 h prior to the procedure to aid intraoperative identification of the thoracic duct.
The primary endpoint was resolution of chyle leak, defined as a reduction in chest drainage to less than 200 mL/day of non-milky fluid. Secondary endpoints included length of hospital stay, post-operative complications, and mortality. Statistical analysis was performed using SPSS Statistics version 26.0 (Armonk, NY: IBM Corp.) for Windows. Continuous variables were compared using Student’s t-test and categorical variables using Fisher’s exact test. Statistical significance was set at p<0.05.
This study was approved by the Institutional Ethics Committee of Guru Gobind Singh Medical College, Faridkot (#GGS/IEC/014, dated June 17, 2025), and all information was collected in accordance with the ethical standards of the ICMR National Ethical Guidelines for Biomedical and Health Research involving human participants.
Results
A total of 500 patients underwent esophagectomy during the study period, of whom six (1.2%) developed post-operative chyle leak. Baseline characteristics for all patients are summarized in Table 1. Patients with chyle leak were significantly younger compared with those without leak (44.0±5.7 vs. 53.2±13.4 years; p=0.009). No statistically significant differences were observed between groups in sex distribution, operative duration, blood loss, or mean hospital stay (Table 2).
**Table 2: Comparison of variables between patients with and without chyle leak.*Student’s t-test for continuous variables and Fisher’s exact test or chi-square test for categorical variables.P<0.05 was statistically significant.
Of the six patients with chyle leak, one underwent conservative management, which failed, resulting in death on post-operative day 18. The remaining five patients underwent early thoracic duct ligation, three via a right thoracotomy and two via a transabdominal approach. All five surgically treated patients demonstrated rapid cessation of chyle output, normalization of drainage, earlier drain removal, and shorter hospitalization, averaging 13-14 days (Table 3). No deaths occurred in the surgical group. Overall mortality in the chyle-leak subgroup was 16.7%, attributable solely to the patient who failed conservative therapy. Surgical ligation resulted in 100% success in 5/6 cases; the only mortality occurred in the conservatively managed patient.
Discussion
Chyle leak after esophagectomy, although infrequent, represents one of the most physiologically exhausting post-operative complications. The incidence in our study (1.2%) lies within the range reported by major series, where rates between 1% and 4% have been consistently documented [1,2]. Loss of chyle results in rapid depletion of lymphocytes, proteins, fats, and electrolytes, leading to immunosuppression, malnutrition, respiratory compromise, and sepsis if inadequately addressed [5]. These metabolic and immune consequences historically contributed to high mortality when early diagnosis and treatment were not pursued [3,6].
Thoracic duct injury most commonly occurs during mediastinal lymphadenectomy and esophageal mobilization, especially in operations involving the middle third of the esophagus or in the presence of ductal anatomical variations [7,8]. Rao et al. demonstrated in their 20-year experience that thoracic duct injury during esophagectomy often results from this anatomical vulnerability and can be difficult to recognize intraoperatively [8]. Such factors complicate prevention and highlight the importance of early post-operative identification.
The role of conservative therapy in managing chyle leak remains a subject of debate. Although bowel rest, total parenteral nutrition, and adequate drainage are generally recommended for low-output leaks, numerous studies, including large esophagectomy cohorts, indicate that high-output chylothorax rarely resolves without operative intervention [3,9]. Persistent drainage leads to continued metabolic decline and is associated with increased morbidity and mortality. This was reflected in our own experience as follows: the only patient treated conservatively experienced progressive deterioration and ultimately died.
In contrast, early surgical ligation has consistently demonstrated excellent results. Brinkmann et al. reported 100% success when surgical intervention was performed promptly after diagnosis, emphasizing that delayed surgery increases complications and prolongs hospitalization [3]. Minimally invasive thoracic duct ligation techniques have further improved outcomes and reduced morbidity, as demonstrated in recent series by Gheorghe et al. [7]. Similarly, transabdominal ligation has been shown to be an effective and safe alternative approach for post-operative chylothorax, with Schumacher et al. reporting excellent long-term outcomes and minimal complications [12].
Lymphangiography can both diagnose and therapeutically reduce leak output by embolizing leaking lymphatic channels [10,11,15]. While these techniques are increasingly used in specialized centers, their availability remains limited, particularly in low- and middle-income settings. Therefore, surgery continues to be the most universally reliable intervention.
The controversy surrounding prophylactic thoracic duct ligation also warrants consideration. Although proposed as a preventive strategy, evidence remains inconclusive. Some studies suggest potential benefits, whereas others, including an updated review by Liu et al., note no clear reduction in post-operative chyle leaks and highlight variations in surgical practice and anatomical differences [16]. Given the lack of consensus, routine prophylactic ligation remains debated.
Our findings align strongly with the global literature as follows: early thoracic duct ligation is safe, effective, and associated with rapid resolution and zero mortality in high-output leaks. In contrast, conservative therapy carries a substantial risk of failure and clinical deterioration in such patients. Based on these data and existing evidence, our findings support consideration of early operative intervention in selected high-output cases, preferably within 48-72 h after esophagectomy.
Limitations
This study has several limitations that should be acknowledged. First, its retrospective design introduces the potential for selection bias and unmeasured confounding variables inherent to observational research. Second, the number of patients with post-operative chyle leak was small, reflecting the rarity of this complication and limiting statistical power for meaningful subgroup comparisons. Third, treatment allocation was not randomized and was based on clinical judgment in a real-world practice setting, which may influence the interpretation of outcomes. Fourth, advanced interventional radiologic techniques, such as thoracic duct embolization, were not routinely available at our institution during the study period, potentially limiting available treatment options. Finally, the extremely small sample size limits external generalizability, and the findings should therefore be interpreted as descriptive institutional experience rather than definitive comparative evidence. Larger multicenter studies would be required to establish stronger treatment recommendations.
Conclusions
Early thoracic duct ligation appears to be a safe and effective treatment option for high-output post-esophagectomy chyle leak in our institutional experience. Conservative therapy may remain appropriate for selected low-output cases. Given the rarity of this complication, our findings should be interpreted as descriptive observational data that align with existing literature rather than definitive comparative evidence.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Chylothorax following resection of the oesophagus Br J Surg Lam KH Lim ST Wong J Ong GB 10510966197942097810.1002/bjs.1800660208 · doi ↗ · pubmed ↗
- 2Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?Aust N Z J Surg Rindani R Martin CJ Cox MR 1871946919991007535710.1046/j.1440-1622.1999.01520.x · doi ↗ · pubmed ↗
- 3Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus J Thorac Cardiovasc Surg Brinkmann S Schroeder W Junggeburth K Gutschow CA Bludau M Hoelscher AH Leers JM 1398140415120162693601110.1016/j.jtcvs.2016.01.030 · doi ↗ · pubmed ↗
- 4Intractable chylous leak after radical esophagectomy treated with radiotherapy J Cardiothorac Surg Ahn S Lee H Kang JK 18202310.1186/s 13019-023-02419-7PMC 1064708937964362 · doi ↗ · pubmed ↗
- 5The management of chylothorax Chest Valentine VG Raffin TA 5865911021992164395310.1378/chest.102.2.586 · doi ↗ · pubmed ↗
- 6Traumatic chylothorax; a review of the literature and report of a case treated by mediastinal ligation of the thoracic duct J Thorac Surg Lampson RS 778791171948 https://pubmed.ncbi.nlm.nih.gov/18102742/18102742 · pubmed ↗
- 7Management of chylothorax in esophageal surgery by minimally invasive thoracoscopic approach: case series Chirurgia (Bucur) Gheorghe M Achim F Hoara P Constantin A Constantinoiu S 23023611720223553578610.21614/chirurgia.2722 · doi ↗ · pubmed ↗
- 8Thoracic duct injury during esophagectomy: 20 years experience at a tertiary care center in a developing country Dis Esophagus Rao DV Chava SP Sahni P Chattopadhyay TK 1411451720041523072710.1111/j.1442-2050.2004.00391.x · doi ↗ · pubmed ↗
